Real-World Treatment Patterns in Patients with Metastatic Castration-Sensitive Prostate Cancer in Japan: A Retrospective Health Administrative Data Analysis

Use of ARSIs for mCSPC is increasing, but ADT alone and ADT plus NSAA are still frequently used. The longer treatment duration among patients who received ARSIs indicates that treatment intensification with ARSIs is vital for mCSPC disease control.